| For: | Jia JJ, Lin BY, He JJ, Geng L, Kadel D, Wang L, Yu DD, Shen T, Yang Z, Ye YF, Zhou L, Zheng SS. ''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation. World J Gastroenterol 2014; 20(32): 11363-11369 [PMID: 25170223 DOI: 10.3748/wjg.v20.i32.11363] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i32/11363.htm |
| Number | Citing Articles |
| 1 |
Shaik Mohammad Naushad, Addepalli Pavani, Yedluri Rupasree, Tajamul Hussain, Salman A. Alrokayan, Vijay Kumar Kutala. Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases. Pharmacological Reports 2019; 71(3) doi: 10.1016/j.pharep.2019.01.006
|
| 2 |
Florian Lemaitre, Camille Tron, Thomas Renard, Caroline Jézéquel, Pauline Houssel-Debry, Damien Bergeat, Cédric Pastoret, Nicolas Collet, Antoine Petitcollin, Marie-Clémence Verdier, Edouard Bardou-Jacquet, Christophe Camus, Karim Boudjema, Eric Bellissant, Michel Rayar. Redefining Therapeutic Drug Monitoring of Tacrolimus in Patients Undergoing Liver Transplantation: A Target Trough Concentration of 4–7 ng/mL During the First Month After Liver Transplantation is Safe and Improves Graft and Renal Function. Therapeutic Drug Monitoring 2020; 42(5) doi: 10.1097/FTD.0000000000000779
|
| 3 |
Rao Fu, Soichiro Tajima, Kimitaka Suetsugu, Hiroyuki Watanabe, Nobuaki Egashira, Satohiro Masuda. Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation. Acta Pharmacologica Sinica 2019; 40(2) doi: 10.1038/s41401-018-0070-2
|
| 4 |
Chih-Yang Hsiao, Ming-Chih Ho, Cheng-Maw Ho, Yao-Ming Wu, Po-Huang Lee, Rey-Heng Hu. Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation. Journal of Personalized Medicine 2021; 11(2) doi: 10.3390/jpm11020090
|
| 5 |
Mohamad-Sherif Mogawer, Mostafa EL-Shazly, Ayman Salah, Amany Abdel-Maqsod, Omar Abdelaziz, Ahmed Abdel-Ghani, Mahmoud Essam, Abeer Awad Abdellatif. Tacrolimus-induced posterior reversible encephalopathy syndrome presenting as left upper limb monoplegia, convulsions, and sudden blindness: case report. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00064-6
|
| 6 |
Tommaso Maria Manzia, Bruno Sensi, Luigi Eduardo Conte, Leandro Siragusa, Roberta Angelico, Francesco Frongillo, Giuseppe Tisone. Evaluation of Humoral Response following SARS-CoV-2 mRNA-Based Vaccination in Liver Transplant Recipients Receiving Tailored Immunosuppressive Therapy. Journal of Clinical Medicine 2023; 12(21) doi: 10.3390/jcm12216913
|
| 7 |
Mikel Gastaca, Patricia Ruiz, Javier Bustamante, Lorea Martinez-Indart, Alberto Ventoso, José Ramón Fernandez, Ibone Palomares, Mikel Prieto, Milagros Testillano, Patricia Salvador, Maria Senosiain, Maria Jesus Suárez, Andres Valdivieso. Early tacrolimus exposure does not impact long-term outcomes after liver transplantation. World Journal of Hepatology 2021; 13(3): 362-374 doi: 10.4254/wjh.v13.i3.362
|
| 8 |
Victor Dong, Mitra K. Nadim, Constantine J. Karvellas. Post–Liver Transplant Acute Kidney Injury. Liver Transplantation 2021; 27(11) doi: 10.1002/lt.26094
|
| 9 |
Jun-Jun Jia, Shi-Yu Zhang, Jun Yu, Hai-Yang Xie, Lin Zhou, Shu-Sen Zheng. The immune profiles and “minimizing tacrolimus” strategy for long-term survival recipients after liver transplantation. Hepatobiliary & Pancreatic Diseases International 2021; 20(2) doi: 10.1016/j.hbpd.2020.08.004
|
| 10 |
James M. Neuberger, Wolf O. Bechstein, Dirk R.J. Kuypers, Patrizia Burra, Franco Citterio, Sabina De Geest, Christophe Duvoux, Alan G. Jardine, Nassim Kamar, Bernhard K. Krämer, Herold J. Metselaar, Frederik Nevens, Jacques Pirenne, Manuel L. Rodríguez-Perálvarez, Didier Samuel, Stefan Schneeberger, Daniel Serón, Pavel Trunečka, Giuseppe Tisone, Teun van Gelder. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients. Transplantation 2017; 101(4S) doi: 10.1097/TP.0000000000001651
|
| 11 |
Paola Hoff Alves, Vittoria Sampaio, Alexandre de Araújo, Caroline Tortato, Mário Reis Álvares da Silva. Tempo entre Início do Uso de Tacrolimo e Nível Sanguíneo Alvo em Pacientes Pós-Transplante Hepático Adulto. Brazilian Journal of Transplantation 2022; 25(4) doi: 10.53855/bjt.v25i4.467_PT
|
| 12 |
M. Xiao, X. Xu, H. Zhu, R. Zhuang, P. Xiang, T. Wang, L. Zhuang, Q. Wei, X. Wei, L. Zhang, J. Wu, S. Zheng. Efficacy and safety of basiliximab in liver transplantation for patients with hepatitis B virus-related diseases: a single centre study. International Journal of Clinical Practice 2015; 69 doi: 10.1111/ijcp.12665
|
| 13 |
Juan Manuel Rico-Juri, Anabel Vanín-Aguas, Felipe Castro-Villegas, Michael Zapata-Palomino, Ilich Andrei Zúñiga-Gaitán, Jesús David Charfuelan-Caicedo, Carolina Téllez-Fina. Eficacia y seguridad del tacrolimus en monoterapia a dosis bajas en trasplante hepático: Experiencia en un hospital nivel IV de Cali. Revista Colombiana de Cirugía 2026; doi: 10.30944/20117582.3074
|
| 14 |
Jiu-lin Song, Ming Li, Lu-Nan Yan, Jia-Yin Yang, Jian Yang, Li Jiang. Higher tacrolimus blood concentration is related to increased risk of post-transplantation diabetes mellitus after living donor liver transplantation. International Journal of Surgery 2018; 51 doi: 10.1016/j.ijsu.2017.12.037
|
| 15 |
Kazuhiro Ishii, Fumiko Yamamoto, Shinsuke Homma, Yoshinori Okada, Kazuo Nakamichi, Masayuki Saijo, Akira Tamaoka. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review. BMC Neurology 2019; 19(1) doi: 10.1186/s12883-019-1493-1
|
| 16 |
Ping-Fang Chiu, Pei-Ru Lin, Chun-Chieh Tsai, Yao-Peng Hsieh. The impact of acute kidney injury with or without recovery on long-term kidney outcome in patients undergoing living liver transplantation. Nephrology Dialysis Transplantation 2023; 38(8) doi: 10.1093/ndt/gfad005
|
| 17 |
Marijn Thijssen, Frank Tacke, Leen Beller, Ward Deboutte, Kwe Claude Yinda, Frederik Nevens, Wim Laleman, Marc Van Ranst, Mahmoud Reza Pourkarim. Clinical relevance of plasma virome dynamics in liver transplant recipients. EBioMedicine 2020; 60 doi: 10.1016/j.ebiom.2020.103009
|
| 18 |
Kerstin Herzer, Martina Sterneck, Martin-Walter Welker, Silvio Nadalin, Gabriele Kirchner, Felix Braun, Christina Malessa, Adam Herber, Johann Pratschke, Karl Heinz Weiss, Elmar Jaeckel, Frank Tacke. Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany. Journal of Clinical Medicine 2020; 9(11) doi: 10.3390/jcm9113570
|
| 19 |
Jiu-Lin Song, Wei Gao, Yan Zhong, Lu-Nan Yan, Jia-Yin Yang, Tian-Fu Wen, Bo Li, Wen-Tao Wang, Hong Wu, Ming-Qing Xu, Zhe-Yu Chen, Yong-Gang Wei, Li Jiang, Jian Yang. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation. World Journal of Gastroenterology 2016; 22(6): 2133-2141 doi: 10.3748/wjg.v22.i6.2133
|
| 20 |
Andrew Stephens, Robert Nidetz, Nicolas Mesyngier, Meng Ting Chung, Yujing Song, Jianping Fu, Katsuo Kurabayashi. Mass-producible microporous silicon membranes for specific leukocyte subset isolation, immunophenotyping, and personalized immunomodulatory drug screening in vitro. Lab on a Chip 2019; 19(18) doi: 10.1039/C9LC00315K
|
| 21 |
Paola Hoff Alves, Vittoria Sampaio, Alexandre de Araújo, Caroline Tortato, Mário Reis Álvares da Silva. Time Between Start of Tacrolimus Use and Target Serum Level in Patients After Adult Liver Transplantation. Brazilian Journal of Transplantation 2022; 25(4) doi: 10.53855/bjt.v25i4.467_IN
|
| 22 |
Jianliang Min, Qihao Li, Weijie Lai, Zi Liu, Guodong Chen. Towards Personalized Tacrolimus Dosing Using an Algorithm-Driven Prediction Pipeline for Kidney Transplant. Drug Design, Development and Therapy 2026; doi: 10.2147/DDDT.S575125
|
| 23 |
Baojie Shi, Yuan Liu, Dehua Liu, Liyun Yuan, Wenzhi Guo, Peihao Wen, Zhaojie Su, Jie Wang, Shiquan Xu, Junjie Xia, Wenbin An, Rui Wang, Peizhen Wen, Tonghai Xing, Jinyan Zhang, Haitao Gu, Zhaowen Wang, Lin Zhong, Junwei Fan, Hao Li, Weituo Zhang, Zhihai Peng. Genotype-guided model significantly improves accuracy of tacrolimus initial dosing after liver transplantation. eClinicalMedicine 2023; 55 doi: 10.1016/j.eclinm.2022.101752
|
| 24 |
Mercè Brunet, Teun van Gelder, Anders Åsberg, Vincent Haufroid, Dennis A. Hesselink, Loralie Langman, Florian Lemaitre, Pierre Marquet, Christoph Seger, Maria Shipkova, Alexander Vinks, Pierre Wallemacq, Eberhard Wieland, Jean Baptiste Woillard, Markus J. Barten, Klemens Budde, Helena Colom, Maja-Theresa Dieterlen, Laure Elens, Kamisha L. Johnson-Davis, Paweł K. Kunicki, Iain MacPhee, Satohiro Masuda, Binu S. Mathew, Olga Millán, Tomoyuki Mizuno, Dirk-Jan A. R. Moes, Caroline Monchaud, Ofelia Noceti, Tomasz Pawinski, Nicolas Picard, Ron van Schaik, Claudia Sommerer, Nils Tore Vethe, Brenda de Winter, Uwe Christians, Stein Bergan. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report. Therapeutic Drug Monitoring 2019; 41(3) doi: 10.1097/FTD.0000000000000640
|
| 25 |
Tommaso Di Maira, Gonzalo Sapisochin, Les Lilly, Victoria Fonés, Marina Berenguer. Posttransplant Calcineurin Inhibitors Levels and Intrapatient Variability Are Not Associated With Long-term Outcomes Following Liver Transplantation. Transplantation 2020; 104(6) doi: 10.1097/TP.0000000000002987
|
| 26 |
Azza Abd El-rahman Saab, Eman Saleh El-hadidi, Maha Mohsen Hussein, Maram Saeed Abd El-baki Shararah, Heba Hassan Aly. Clinical utility of ABCB1 single nucleotide polymorphism on tacrolimus dose requirements in Egyptian liver transplant patients. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00127-2
|
| 27 |
Grzegorz Kowalewski, Piotr Kaliciński, Marek Stefanowicz, Ryszard Grenda, Piotr Czubkowski, Marek Szymczak. Long-Term Follow-Up of Renal Function in Children after Liver Transplantation—A Single Center Retrospective Study. Children 2021; 8(8) doi: 10.3390/children8080633
|
| 28 |
Paola Hoff Alves, Vittoria Sampaio, Alexandre de Araújo, Caroline Tortato, Mário Reis Álvares da Silva. Tiempo entre el Uso de Tacrolimo y el Nivel Sérico Objetivo en Pacientes Después de un Trasplante Hepático en Adultos. Brazilian Journal of Transplantation 2022; 25(4) doi: 10.53855/bjt.v25i4.467_ESP
|
| 29 |
Jian-Wen Jiang, Zhi-Gang Ren, Hai-Feng Lu, Hua Zhang, Ang Li, Guang-Ying Cui, Jun-Jun Jia, Hai-Yang Xie, Xin-Hua Chen, Yong He, Li Jiang, Lan-Juan Li. Optimal immunosuppressor induces stable gut microbiota after liver transplantation. World Journal of Gastroenterology 2018; 24(34): 3871-3883 doi: 10.3748/wjg.v24.i34.3871
|
| 30 |
María Eugenia Cornide-Petronio, Ana Isabel Álvarez-Mercado, Mónica B. Jiménez-Castro, Carmen Peralta. Current Knowledge about the Effect of Nutritional Status, Supplemented Nutrition Diet, and Gut Microbiota on Hepatic Ischemia-Reperfusion and Regeneration in Liver Surgery. Nutrients 2020; 12(2) doi: 10.3390/nu12020284
|
| 31 |
Franck-Nicolas Bardou, Olivier Guillaud, Domitille Erard-Poinsot, Christine Chambon-Augoyard, Elsa Thimonier, Mélanie Vallin, Olivier Boillot, Jérôme Dumortier. Tacrolimus exposure after liver transplantation for alcohol-related liver disease: Impact on complications. Transplant Immunology 2019; 56 doi: 10.1016/j.trim.2019.101227
|
| 32 |
Ali R Chaitou, Surbhi Valmiki, Mrinaal Valmiki, Maria Zahid, Mohamed A Aid, Peter Fawzy, Safeera Khan. New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy. Cureus 2022; doi: 10.7759/cureus.23635
|